论文部分内容阅读
选择我院于2015年2月~2016年6月期间收治的70例2型糖尿患者,随机分为对照组(35例)给予瑞格列奈治疗,观察组(35例)在对照组的基础上给予甘精胰岛素治疗。结果治疗后观察组患者的FPG、2hPG、HbA_(1c)水平均低于对照组(P<0.05);β细胞功能明显改善(P<0.05);不良反应的发生率明显低于对照组,(P<0.05)。结论观察组有效改善血糖分水平及β细胞功能,减少不良反应。
A total of 70 patients with type 2 diabetes treated in our hospital from February 2015 to June 2016 were randomly divided into control group (n = 35) treated with repaglinide and observation group (n = 35) based on control group On insulin glargine treatment. Results The levels of FPG, 2hPG and HbA 1c in the observation group were significantly lower than those in the control group (P <0.05); the function of β cells was significantly improved (P <0.05); the incidence of adverse reactions was significantly lower than that in the control group P <0.05). Conclusion The observation group can effectively improve blood glucose level and β-cell function and reduce adverse reactions.